|
(In millions) (Unaudited) |
Three Months Ended March 31, |
Nine Months Ended March 31, |
|||
|---|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | ||
| Operations | |||||
| Net income |
$
31,778
|
$
25,824
|
$
97,983
|
$
74,599
|
|
| Adjustments to reconcile net income to net cash from operations: | |||||
| Depreciation, amortization, and other |
10,167
|
7,734
|
27,512
|
20,116
|
|
| Stock-based compensation expense |
3,081
|
2,980
|
9,283
|
8,901
|
|
| Net recognized losses (gains) on investments and derivatives |
(1,280)
|
708
|
(7,304)
|
3,387
|
|
| Deferred income taxes |
2,602
|
(2,244)
|
9,539
|
(4,835)
|
|
| Changes in operating assets and liabilities: | |||||
| Accounts receivable |
(4,707)
|
(2,461)
|
8,347
|
5,598
|
|
| Inventories |
(161)
|
52
|
(283)
|
390
|
|
| Other current assets |
758
|
1,076
|
215
|
642
|
|
| Other long-term assets |
(932)
|
(518)
|
(2,614)
|
(3,368)
|
|
| Accounts payable |
2,320
|
1,179
|
2,903
|
1,221
|
|
| Unearned revenue |
(166)
|
(1,032)
|
(13,067)
|
(12,923)
|
|
| Income taxes |
2,296
|
1,298
|
(1,568)
|
(1,081)
|
|
| Other current liabilities |
2,539
|
2,839
|
(166)
|
576
|
|
| Other long-term liabilities |
(1,616)
|
(391)
|
(3,286)
|
292
|
|
| Net cash from operations |
46,679
|
37,044
|
127,494
|
93,515
|
|
| Financing | |||||
| Repayments of debt, maturities of 90 days or less |
0
|
0
|
0
|
(5,746)
|
|
| Repayments of debt |
0
|
(2,250)
|
(3,000)
|
(3,216)
|
|
| Common stock issued |
541
|
546
|
1,489
|
1,508
|
|
| Common stock repurchased |
(4,627)
|
(4,781)
|
(17,692)
|
(13,874)
|
|
| Common stock cash dividends paid |
(6,756)
|
(6,169)
|
(19,687)
|
(17,913)
|
|
| Other, net |
(509)
|
(382)
|
(1,877)
|
(1,614)
|
|
| Net cash used in financing |
(11,351)
|
(13,036)
|
(40,767)
|
(40,855)
|
|
| Investing | |||||
| Additions to property and equipment |
(30,876)
|
(16,745)
|
(80,146)
|
(47,472)
|
|
| Acquisition of companies, net of cash acquired and divestitures, and purchases of intangible and other assets |
(258)
|
(981)
|
(1,291)
|
(4,235)
|
|
| Purchases of investments |
(12,006)
|
(4,474)
|
(39,522)
|
(8,144)
|
|
| Maturities of investments |
11,976
|
6,721
|
30,424
|
11,461
|
|
| Sales of investments |
6,358
|
2,161
|
15,311
|
6,688
|
|
| Other, net |
(2,599)
|
604
|
(9,445)
|
(325)
|
|
| Net cash used in investing |
(27,405)
|
(12,714)
|
(84,669)
|
(42,027)
|
|
| Effect of foreign exchange rates on cash and cash equivalents |
(114)
|
52
|
(195)
|
(120)
|
|
| Net change in cash and cash equivalents |
7,809
|
11,346
|
1,863
|
10,513
|
|
| Cash and cash equivalents, beginning of period |
24,296
|
17,482
|
30,242
|
18,315
|
|
| Cash and cash equivalents, end of period |
$
32,105
|
$
28,828
|
$
32,105
|
$
28,828
|
|
We have recast certain prior period amounts to conform to the current period presentation.
IMPORTANT NOTICE TO USERS
(summary only,
click
here
for full text of notice)
All information is unaudited unless otherwise noted or accompanied
by an audit opinion and
is subject to the more comprehensive information contained in our SEC reports and filings. We do not endorse
third-party
information. All information speaks as of the last fiscal quarter or year for which we have filed a Form 10-K
or 10-Q, or
for historical information the date or period expressly indicated in or with such information. We undertake no
duty to update
the information. Forward-looking statements are subject to risks and uncertainties described in our
Forms
10-Q and 10-K.
Download Earnings Related Files
Information contained in these documents is current as of the earnings date, and not restated for new accounting standards
Earnings Release Pages
Microsoft Corp (MSFT)
Follow us